Rae Hyndman was diagnosed with advanced ovarian cancer in November 2023, after noticing bloating in her stomach.

A Fife woman living with stage four incurable cancer is set to take on Sir Chris Hoy’s cycling challenge in Glasgow. At the ...

A woman who struggled to recover from a bout of food poisoning after her Christmas work do went on to be diagnosed with a ...

Lindsay Barad felt like she was in the best shape of her life. But everything changed after a doctor's appointment revealed ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights that could help researchers develop more effective treatment strategies.

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in patients with platinum-sensitive ovarian cancer.

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves - insights that could help researchers develop more effective treatment strategies.

DNA G-quadruplexes appear to substantially help ovarian cancer cells activate genes that counteract chemotherapy, effectively shielding the tumor from treatment.

CORT's relacorilant combo targets platinum-resistant ovarian cancer in new NDA, backed by positive ROSELLA study data.

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that the primary analysis of the Phase 2 RAMP ...